Attached files
| file | filename |
|---|---|
| S-1 - FORM S-1 - ATOSSA THERAPEUTICS, INC. | atos20201113_s1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Atossa Therapeutics, Inc.
Seattle, Washington
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement on Form S-1 of our report dated March 26, 2020, relating to the consolidated financial statements of Atossa Therapeutics, Inc. (the “Company”), appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/BDO USA, LLP
Seattle, Washington
November 20, 2020